NCT00904397 - Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

November 30, 2004

Conditions

Chronic Low Back Pain

Interventions

DRUG

Lidoderm®

Patients participated in a 14-day washout period followed by a 12-week active treatment period. Eligible patients were randomized equally to one of two groups: lidocaine patch 5% or celecoxib 200 mg.

DRUG

Celecoxib

Patients participated in a 14-day washout period followed by a 12-week active treatment period. Eligible patients were randomized equally to one of two groups: lidocaine patch 5% or celecoxib 200 mg.

Trial Locations (21)

Unknown

Northport

Phoenix

Beverly Hills

Encinitas

San Diego

Spring Valley

Longwood

North Miami Beach

Plantation

Chicago

Shreveport

Boston

Berlin

Bethpage

Tonawanda

Charlotte

Dayton

Allentown

Sellersville

Greer

Spokane